Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
44,443
-
Share change
-
+3,165
-
Total reported value
-
$65,000
-
Price per share
-
$1.53
-
Number of holders
-
6
-
Value change
-
-$25,998
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2016
As of 31 Mar 2016,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,443 shares.
The largest 6 holders included
VANGUARD GROUP INC, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and BlackRock Fund Advisors.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.